课题基金 / 基金详情

Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus

Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus
效应器检查点 TcR 信号强度对保护性 CD4 T 细胞对流感病毒免疫的影响
批准号:
10187518
负责人:
SUSAN L SWAIN
金额:
$20.94万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-09 至 2022-05-31

项目摘要

项目成果

SUSAN L SWAIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus. Our recent studies show that the development of CD4 memory requires CD4 effectors to again recognize antigen from influenza virus in order to differentiate to memory. Many non-live vaccines, optimized for safety, induce strong antigen presentation only for a few days and they fail to induce robust CD4 T cell memory or long-lived B cell responses, dependent on CD4 helper effectors. Preliminary results indicate high doses of Ag are needed. We propose to determine the impact of CD4 signal strength, both dose and affinity for the TcR, on the quantity and quality of CD4 memory and on CD4 effectors specialized for helping B cells. We will determine whether the CD4 memory obtained is protective and whether providing high signal strength in responses to vaccine can improve their ability to induce CD4 memory and helper effectors. If high dose and affinity are indeed needed at the effector stage for protective responses, vaccine strategies would need to be altered to ensure the signals needed are provided.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Direct IL-6 Signals Maximize Protective Secondary CD4 T Cell Responses against Influenza.
直接 IL-6 信号可最大限度地提高针对流感的保护性次级 CD4 T 细胞反应。
DOI: 10.4049/jimmunol.1600033
发表时间: 2016
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Strutt,TaraM, McKinstry,KarlKai, Kuang,Yi, Finn,CarolineM, Hwang,JiHae, Dhume,Kunal, Sell,Stewart, Swain,SusanL]
通讯作者: Swain,SusanL
Harnessing Age-Associated B cells for a Universal Influenza Vaccine for the Aged
Age-Associated B Cells Specialized for Immunity to Pathogens?
Age-Associated B Cells Specialized for Immunity to Pathogens?
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus
海外基金